Nu-Med Plus, Inc. (NUMD)
Q2-CY2026Q1-CY2026Q4-CY2025Q3-CY2025Q2-CY2025Q1-CY2025Q4-CY2024Q3-CY2024Q2-CY2024Q1-CY2024Q4-CY2023Q3-CY2023Q2-CY2023Q1-CY2023Q4-CY2022Q3-CY2022Q2-CY2022Q1-CY2022Q4-CY2021Q3-CY2021Q2-CY2021Q1-CY2021Q4-CY2020Q3-CY2020Q2-CY2020Q1-CY2020Q4-CY2019Q3-CY2019Q2-CY2019Q1-CY2019Q4-CY2018Q3-CY2018Q2-CY2018Q1-CY2018Q4-CY2017Q3-CY2017Q2-CY2017Q1-CY2017Q4-CY2016Q3-CY2016Q2-CY2016Q1-CY2016Q4-CY2015Q3-CY2015Q2-CY2015Q1-CY2015Q4-CY2014Q3-CY2014Q2-CY2014
Balance Sheet Date2025-Dec-312025-Sep-302025-Jun-302025-Mar-312024-Dec-312024-Sep-302024-Jun-302024-Mar-312023-Dec-312021-Dec-312021-Sep-302021-Jun-302021-Mar-312020-Dec-312020-Sep-302020-Jun-302020-Mar-312019-Dec-312019-Sep-302019-Jun-302019-Mar-312018-Dec-312018-Sep-302018-Jun-302018-Mar-312017-Dec-312017-Sep-302017-Jun-302017-Mar-312016-Dec-312016-Sep-302016-Jun-302016-Mar-312015-Dec-312015-Sep-302015-Jun-302015-Mar-312014-Dec-312014-Sep-302014-Jun-30
Fiscal PeriodQ4-FY2025Q3-FY2025Q2-FY2025Q1-FY2025Q4-FY2024Q3-FY2024Q2-FY2024Q1-FY2024Q4-FY2023Q4-FY2021Q3-FY2021Q2-FY2021Q1-FY2021Q4-FY2020Q3-FY2020Q2-FY2020Q1-FY2020Q4-FY2019Q3-FY2019Q2-FY2019Q1-FY2019Q4-FY2018Q3-FY2018Q2-FY2018Q1-FY2018Q4-FY2017Q3-FY2017Q2-FY2017Q1-FY2017Q4-FY2016Q3-FY2016Q2-FY2016Q1-FY2016Q4-FY2015Q3-FY2015Q2-FY2015Q1-FY2015Q4-FY2014Q3-FY2014Q2-FY2014
Operating Cash Flow(35,054$)(11,415$)(1,668$)0$(2,315$)(450$)(4,282$)(18,869$)(23,072$)(20,166$)(20,165$)(40,991$)(66,434$)(79,241$)(71,252$)(101,020$)(147,337$)(95,190$)(124,665$)(75,462$)(120,519$)(246,695$)(143,330$)(142,931$)(99,552$)(81,755$)(139,180$)(127,832$)(89,595$)(73,903$)(41,244$)(38,948$)(49,809$)(50,263$)(47,518$)(39,297$)(52,802$)(43,290$)(36,714$)(35,286$)(42,378$)
Investing Cash Flow0$0$0$0$0$0$0$0$0$1$0$(5,026$)0$0$0$0$0$0$0$0$0$0$0$0$0$(1,101$)0$0$
Purchases of Property and Equipment0$1$0$0$0$(1,101$)0$0$
Financing Cash Flow33,767$0$0$0$30,000$228,260$126,412$135,115$106,439$89,906$101,614$112,929$102,458$142,580$22,795$117,556$6,132$80,910$273,606$35,587$379,000$52,311$2,500$0$107,000$78,210$28,800$50,529$0$0$90,001$73,999$
End Cash Position661$1,948$863$2,373$2,373$4,041$4,041$6,356$6,806$11,088$29,957$53,029$73,195$11,675$31,840$72,831$139,265$188,506$31,498$6,106$18,328$7,079$41,838$15,686$23,276$167,513$168,262$288,398$275,420$351,043$409,313$263,539$315,547$12,450$1,383$37,831$87,640$30,903$211$10,708$12,981$56,271$94,086$39,371$
Exchange Rate Effect
Dividends Paid
Unlevered Free Cash Flow(35,054$)(11,415$)(1,668$)0$(2,315$)(450$)(4,282$)(18,869$)(23,072$)(20,166$)(20,165$)(40,991$)(66,434$)(79,241$)(71,252$)(101,020$)(147,337$)(95,190$)(124,665$)(75,462$)(120,519$)(246,695$)(143,331$)(142,931$)(99,552$)(81,755$)(139,180$)(127,832$)(89,595$)(73,903$)(41,244$)(38,948$)(49,809$)(50,263$)(47,518$)(39,297$)(52,802$)(43,290$)(35,613$)(35,286$)(42,378$)